Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
-
Field
-
The Department of Medical Biosciences is offering a postdoctoral scholarship within the project “Developing computational tools for large-scale human intracellular signaling models”. The scholarship
-
signaling models”. The scholarship is full-time for 2 years, with access starting in May 2026 or by agreement. The research will be carried out in the laboratory of Cemal Erdem at the Department of Medical
-
sources, uncertainty quantification analysis of time series data and dynamic processes, where signals and responses evolve over time. Work with a wide range of data types, for example dietary records
-
apply is 18 February, 2026. Description of the project Hypoxia inhibits appetite, yet the underlying mechanisms remain poorly understood. Our recent findings implicate GPCR signaling as a potential
-
. for electrification of the vehicle industry – sustainability in materials and processes is of the highest importance. Regardless of the battery chemistry understudy, a circular battery value chain relies on efficient
-
quantification analysis of time series data and dynamic processes, where signals and responses evolve over time. Work with a wide range of data types, for example dietary records, biomarkers, omics data, registry
-
duties are to do defect analysis and development of new techniques for sample preparation and imaging (for instance using luminescence and microscopy). Also, computer simulations can be performed. Examples
-
virus may explain the remarkably strong link between HCMV and glioblastoma, and potentially its association with other tumor types. Our emerging findings indicate that alterations in host cell metabolism
-
about life science research at Umeå University (Video ). Project description Autophagy is an evolutionarily conserved self-eating process mainly purposed to eliminate or recycle dysfunctional cellular
-
for human cytomegalovirus (HCMV), a virus that enhances tumor aggressiveness. High viral activity in GBM correlates with poor patient outcomes. Importantly, our clinical studies indicate that antiviral